Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma

Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung Adenocarcinoma

Lung cancer is the leading cause of cancer-related death in the United States. Here, we evaluated the potential clinical utility of soluble human epidermal growth factor receptor 2 (sHER2) for the risk assessment, screening, and diagnosis of non-small cell lung cancer (NSCLC) using an unmatched case...

Full description

Bibliographic Details
Main Authors: Andre T. Baron, Nita J. Maihle, Ping Yang, Adam J. Branscum, Yuxia Wang, Marites C. Buenafe, Kimberly D. Kimbler, Tammy M. Greenwood, Abby L. Cosentino-Boehm, Jacqueline M. Lafky
Format: Article
Language:English
Published: MDPI AG 2013-01-01
Series:Diagnostics
Subjects:
soluble human epidermal growth factor receptor 2 (sHER2)
non-small cell lung cancer
adenocarcinoma
squamous cell carcinoma (SCC)
risk assessment
screening
early detection
diagnosis
Online Access:http://www.mdpi.com/2075-4418/3/1/13

Internet

http://www.mdpi.com/2075-4418/3/1/13

Similar Items